Skip to content
Screener

Chemours CC Other Non-Reportable — D&A

Similar metrics at other companies

flyExclusive logo
FLYXReportable — D&A
$5.18M-17.1%
Lifevantage Corporation logo
LFVNReportable — D&A
$714K-11.0%
Dollar General logo
DGSingle Reportable — D&A
$260M+7.0%
OLP
OLPXReportable Segment — D&A
$13.32M-0.4%
V2X logo
VVXReportable Segment — D&A
$28.11M+0.3%
Anterix logo
ATEXReportable Segment — D&A
$103K+35.5%

Other financials

Income statement

See full
Revenue$1.6B-1.5%
Gross profit$286.0M+2.9%
Net income-$274.0M+27.9%
EPS (diluted)-$1.81+28.5%

Balance sheet

See full
Cash & equivalents$671.0M+33.7%
Total debt$4.2B-6.5%
Total equity-$49.0M-121%
Total assets$7.2B-4.2%

Cash flow

See full
Operating cash flow$158.0M+69.9%
CapEx$44.0M+2.3%
Free cash flow$114.0M

Valuation

See full
Market cap$2.27B+26.6%
Enterprise value$5.76B+0.4%
P/S0.4×+0.1×

Profitability

See full
Gross margin15.3%-2.9pp
Net margin-5.2%-1.2pp
FCF margin5.1%-1.7pp

Returns & leverage

See full
Return on equity-105%-107pp
Debt / equity20.6×+12.8×
Current ratio1.7×0.0×

Where this comes from

Reported directly by Chemours in its filing.

Tagged under the XBRL concept us-gaap:DepreciationDepletionAndAmortization.

The source filing: Chemours’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 11:06 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001627223-26-000024
Three Months Ended June 30, 2026Segment TotalOther Non-Reportable SegmentCorporateTotal Consolidated
Net sales to external customers$$1,578$131,591
Depreciation and amortization$$74$1$580
Six Months Ended June 30, 2026
Net sales to external customers$$2,947$252,972
Depreciation and amortization$$148$2$9159
Purchases of property, plant, and equipment$$90$1$293

Item 1. INTERIM CONSOLIDATED FINANCIAL STATEMENTS

FAQ

What is Chemours's other non-reportable — D&A?
Chemours (CC) reported other non-reportable — D&A of $1M in Q2 2026.
How has Chemours's other non-reportable — D&A changed year-over-year?
Chemours's other non-reportable — D&A decreased by 0.0% year-over-year, from $1M to $1M.
What is the long-term trend for Chemours's other non-reportable — D&A?
Over 3 years (2022 to 2025), Chemours's other non-reportable — D&A has grown at a -20.6% compound annual growth rate (CAGR), from $8M to $4M.
What does other non-reportable — D&A mean?
This metric measures the non-cash expense allocated to the non-reportable segment to account for the gradual consumption of tangible and intangible assets over their useful lives. It provides insight into the capital intensity of these peripheral operations and the ongoing cost of maintaining their asset base. Analysts use this to adjust operating income and assess the true cash-generating capability of the segment.

Ask your AI about Chemours's other non-reportable — d&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude